Robots could give humans ‘superpowers’
By
In a new book, MIT roboticist Daniela Rus looks at the powers and limitations of robots and how humans can work with them to unlock new capabilities.
By
In a new book, MIT roboticist Daniela Rus looks at the powers and limitations of robots and how humans can work with them to unlock new capabilities.
By
Machine learning is a powerful form of artificial intelligence that is affecting every industry. Here’s what you need to know about its potential and limitations and how it’s being used.
By
Africans are waking up to their intrinsic creative prowess. The talent in the film, music, arts, crafts, fashion, design, and multimedia industries that are now available on the continent present infinite opportunities for creative jobs for Africans.
By
In a new book about the history of Kendall Square from the MIT Press, author Robert Buderi chronicles the area's biggest successes in innovation.
By
Stories of entrepreneurs changing the story of Africa. According to one, "People like us — the founders, the movers and the shakers – our stories should also be told widely,” she said. “That story of Africa, we are the face of it. And it is hopeful, it is so much possibility. And hope has to be told...
By
Maria Ressa built a successful media startup — and exposed human rights issues — while fighting disinformation and attacks from the Philippine government.
By
Matt Beane, SM ’14, PhD ’17, argues those using artificial intelligence will become incrementally de-skilled unless they are consciously upskilling at the same time.
By
Fellowship applications open on May 3, 2021 for entrepreneurs working and living in Ethiopia, Ghana, Nigeria, Kenya, Rwanda, Senegal, and Uganda.
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process